{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:19:52Z","timestamp":1776989992560,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,2,27]],"date-time":"2014-02-27T00:00:00Z","timestamp":1393459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s13277-014-1673-y","type":"journal-article","created":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T07:22:26Z","timestamp":1393399346000},"page":"5189-5198","source":"Crossref","is-referenced-by-count":31,"title":["Bone morphogenetic protein 2 inhibits hepatocellular carcinoma growth and migration through downregulation of the PI3K\/AKT pathway"],"prefix":"10.1007","volume":"35","author":[{"given":"Ying","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haidong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,27]]},"reference":[{"issue":"6","key":"1673_CR1","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","volume":"142","author":"HB El-Serag","year":"2012","unstructured":"El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(6):1264\u201373 e1. doi: 10.1053\/j.gastro.2011.12.061 .","journal-title":"Gastroenterology"},{"issue":"37","key":"1673_CR2","doi-asserted-by":"crossref","first-page":"6144","DOI":"10.3748\/wjg.v19.i37.6144","volume":"19","author":"JW Shin","year":"2013","unstructured":"Shin JW, Chung YH. Molecular targeted therapy for hepatocellular carcinoma: current and future. World J Gastroenterol. 2013;19(37):6144\u201355. doi: 10.3748\/wjg.v19.i37.6144 .","journal-title":"World J Gastroenterol"},{"issue":"4885","key":"1673_CR3","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1126\/science.3201241","volume":"242","author":"JM Wozney","year":"1988","unstructured":"Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, et al. Novel regulators of bone formation: molecular clones and activities. Science. 1988;242(4885):1528\u201334.","journal-title":"Science"},{"key":"1673_CR4","author":"H Liu","year":"2013","unstructured":"Liu H, Bao D, Xia X, Chau JF, Li B. An unconventional role of BMP-Smad1 signaling in DNA damage response: a mechanism for tumor suppression. J Cell Biochem. 2013. doi: 10.1002\/jcb.24698 .","journal-title":"J Cell Biochem"},{"issue":"10","key":"1673_CR5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.5483\/BMBRep.2011.44.10.619","volume":"44","author":"M Kim","year":"2011","unstructured":"Kim M, Choe S. BMPs and their clinical potentials. BMB Rep. 2011;44(10):619\u201334.","journal-title":"BMB Rep"},{"issue":"9","key":"1673_CR6","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.7314\/APJCP.2013.14.9.5293","volume":"14","author":"ZH Fei","year":"2013","unstructured":"Fei ZH, Yao CY, Yang XL, Huang XE, Ma SL. Serum BMP-2 up-regulation as an indicator of poor survival in advanced non-small cell lung cancer patients. Asian Pac J Cancer Prev. 2013;14(9):5293\u20139.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"1673_CR7","first-page":"1465","volume":"26","author":"M Raida","year":"2005","unstructured":"Raida M, Clement JH, Ameri K, Han C, Leek RD, Harris AL. Expression of bone morphogenetic protein 2 in breast cancer cells inhibits hypoxic cell death. Int J Oncol. 2005;26(6):1465\u201370.","journal-title":"Int J Oncol"},{"issue":"11","key":"1673_CR8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00432-005-0024-1","volume":"131","author":"M Raida","year":"2005","unstructured":"Raida M, Clement JH, Leek RD, Ameri K, Bicknell R, Niederwieser D, et al. Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis. J Cancer Res Clin Oncol. 2005;131(11):741\u201350. doi: 10.1007\/s00432-005-0024-1 .","journal-title":"J Cancer Res Clin Oncol"},{"issue":"12","key":"1673_CR9","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/pros.20799","volume":"68","author":"TH Lai","year":"2008","unstructured":"Lai TH, Fong YC, Fu WM, Yang RS, Tang CH. Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins. Prostate. 2008;68(12):1341\u201353. doi: 10.1002\/pros.20799 .","journal-title":"Prostate"},{"issue":"43","key":"1673_CR10","doi-asserted-by":"crossref","first-page":"37335","DOI":"10.1074\/jbc.M111.256156","volume":"286","author":"YL Hsu","year":"2011","unstructured":"Hsu YL, Huang MS, Yang CJ, Hung JY, Wu LY, Kuo PL. Lung tumor-associated osteoblast-derived bone morphogenetic protein-2 increased epithelial-to-mesenchymal transition of cancer by Runx2\/Snail signaling pathway. J Biol Chem. 2011;286(43):37335\u201346. doi: 10.1074\/jbc.M111.256156 .","journal-title":"J Biol Chem"},{"issue":"6","key":"1673_CR11","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1016\/j.ajpath.2011.08.022","volume":"179","author":"YT Shirai","year":"2011","unstructured":"Shirai YT, Ehata S, Yashiro M, Yanagihara K, Hirakawa K, Miyazono K. Bone morphogenetic protein-2 and \u22124 play tumor suppressive roles in human diffuse-type gastric carcinoma. Am J Pathol. 2011;179(6):2920\u201330. doi: 10.1016\/j.ajpath.2011.08.022 .","journal-title":"Am J Pathol"},{"issue":"8","key":"1673_CR12","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.27444","volume":"131","author":"L Wang","year":"2012","unstructured":"Wang L, Park P, Zhang H, La Marca F, Claeson A, Than K, et al. BMP-2 inhibits tumor growth of human renal cell carcinoma and induces bone formation. Int J Cancer. 2012;131(8):1941\u201350. doi: 10.1002\/ijc.27444 .","journal-title":"Int J Cancer"},{"issue":"5","key":"1673_CR13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4161\/cbt.11.5.14372","volume":"11","author":"L Wang","year":"2011","unstructured":"Wang L, Park P, Zhang H, La Marca F, Claeson A, Valdivia J, et al. BMP-2 inhibits the tumorigenicity of cancer stem cells in human osteosarcoma OS99\u20131 cell line. Cancer Biol Ther. 2011;11(5):457\u201363.","journal-title":"Cancer Biol Ther"},{"issue":"47","key":"1673_CR14","doi-asserted-by":"crossref","first-page":"7621","DOI":"10.3748\/wjg.v12.i47.7621","volume":"12","author":"CP Xu","year":"2006","unstructured":"Xu CP, Ji WM, van den Brink GR, Peppelenbosch MP. Bone morphogenetic protein-2 is a negative regulator of hepatocyte proliferation downregulated in the regenerating liver. World J Gastroenterol. 2006;12(47):7621\u20135.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"1673_CR15","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s10495-013-0867-x","volume":"18","author":"YH Yang","year":"2013","unstructured":"Yang YH, Chen K, Li B, Chen JW, Zheng XF, Wang YR, et al. Estradiol inhibits osteoblast apoptosis via promotion of autophagy through the ER-ERK-mTOR pathway. Apoptosis. 2013;18(11):1363\u201375. doi: 10.1007\/s10495-013-0867-x .","journal-title":"Apoptosis"},{"key":"1673_CR16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2121-10-20","volume":"10","author":"B Herrera","year":"2009","unstructured":"Herrera B, Inman GJA. Rapid and sensitive bioassay for the simultaneous measurement of multiple bone morphogenetic proteins. Identification and quantification of BMP4, BMP6 and BMP9 in bovine and human serum. BMC Cell Biol. 2009;10:20. doi: 10.1186\/1471-2121-10-20 .","journal-title":"BMC Cell Biol"},{"issue":"3","key":"1673_CR17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3892\/mmr.2012.962","volume":"6","author":"A Chen","year":"2012","unstructured":"Chen A, Wang D, Liu X, He S, Yu Z, Wang J. Inhibitory effect of BMP-2 on the proliferation of breast cancer cells. Mol Med Rep. 2012;6(3):615\u201320. doi: 10.3892\/mmr.2012.962 .","journal-title":"Mol Med Rep"},{"issue":"10","key":"1673_CR18","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1158\/1535-7163.MCT-12-0920","volume":"12","author":"G Wang","year":"2013","unstructured":"Wang G, Cao X, Lai S, Luo X, Feng Y, Xia X, et al. PI3K stimulates DNA synthesis and cell-cycle progression via its p55PIK regulatory subunit interaction with PCNA. Mol Cancer Ther. 2013;12(10):2100\u20139. doi: 10.1158\/1535-7163.MCT-12-0920 .","journal-title":"Mol Cancer Ther"},{"issue":"7","key":"1673_CR19","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/aob\/mcq243","volume":"107","author":"W Strzalka","year":"2011","unstructured":"Strzalka W, Ziemienowicz A. Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation. Ann Bot. 2011;107(7):1127\u201340. doi: 10.1093\/aob\/mcq243 .","journal-title":"Ann Bot"},{"issue":"1","key":"1673_CR20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1530\/eje.0.1480147","volume":"148","author":"S Kang","year":"2003","unstructured":"Kang S, Song J, Kang H, Kim S, Lee Y, Park D. Insulin can block apoptosis by decreasing oxidative stress via phosphatidylinositol 3-kinase- and extracellular signal-regulated protein kinase-dependent signaling pathways in HepG2 cells. Eur J Endocrinol. 2003;148(1):147\u201355.","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"1673_CR21","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1210\/me.2007-0527","volume":"22","author":"YD Wang","year":"2008","unstructured":"Wang YD, Yang F, Chen WD, Huang X, Lai L, Forman BM, et al. Farnesoid X receptor protects liver cells from apoptosis induced by serum deprivation in vitro and fasting in vivo. Mol Endocrinol. 2008;22(7):1622\u201332. doi: 10.1210\/me.2007-0527 .","journal-title":"Mol Endocrinol"},{"issue":"4","key":"1673_CR22","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","volume":"75","author":"JW Harper","year":"1993","unstructured":"Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 1993;75(4):805\u201316.","journal-title":"Cell"},{"issue":"2","key":"1673_CR23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0167-4889(00)00060-4","volume":"1497","author":"N Ghosh-Choudhury","year":"2000","unstructured":"Ghosh-Choudhury N, Ghosh-Choudhury G, Celeste A, Ghosh PM, Moyer M, Abboud SL, et al. Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells. Biochim Biophys Acta. 2000;1497(2):186\u201396.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"1673_CR24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1006\/bbrc.2000.2844","volume":"272","author":"N Ghosh-Choudhury","year":"2000","unstructured":"Ghosh-Choudhury N, Woodruff K, Qi W, Celeste A, Abboud SL, Ghosh Choudhury G. Bone morphogenetic protein-2 blocks MDA MB 231 human breast cancer cell proliferation by inhibiting cyclin-dependent kinase-mediated retinoblastoma protein phosphorylation. Biochem Biophys Res Commun. 2000;272(3):705\u201311. doi: 10.1006\/bbrc.2000.2844 .","journal-title":"Biochem Biophys Res Commun"},{"key":"1673_CR25","first-page":"249","volume":"257","author":"LJ Yang","year":"1990","unstructured":"Yang LJ, Jin Y. Immunohistochemical observations on bone morphogenetic protein in normal and abnormal conditions. Clin Orthop Relat Res. 1990;257:249\u201356.","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"1673_CR26","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s002640050148","volume":"21","author":"M Laitinen","year":"1997","unstructured":"Laitinen M, Jortikka L, Halttunen T, Nevalainen J, Aho AJ, Marttinen A, et al. Measurement of total and local bone morphogenetic protein concentration in bone tumours. Int Orthop. 1997;21(3):188\u201393.","journal-title":"Int Orthop"},{"issue":"7","key":"1673_CR27","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/onc.2012.115","volume":"32","author":"S Braig","year":"2013","unstructured":"Braig S, Bosserhoff AK. Death inducer-obliterator 1 (Dido1) is a BMP target gene and promotes BMP-induced melanoma progression. Oncogene. 2013;32(7):837\u201348. doi: 10.1038\/onc.2012.115 .","journal-title":"Oncogene"},{"issue":"4","key":"1673_CR28","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/path.2563","volume":"218","author":"U Maegdefrau","year":"2009","unstructured":"Maegdefrau U, Amann T, Winklmeier A, Braig S, Schubert T, Weiss TS, et al. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression. J Pathol. 2009;218(4):520\u20139. doi: 10.1002\/path.2563 .","journal-title":"J Pathol"},{"issue":"2","key":"1673_CR29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s13277-012-0594-x","volume":"34","author":"W Li","year":"2013","unstructured":"Li W, Cai HX, Ge XM, Li K, Xu WD, Shi WH. Prognostic significance of BMP7 as an oncogene in hepatocellular carcinoma. Tumour Biol. 2013;34(2):669\u201374. doi: 10.1007\/s13277-012-0594-x .","journal-title":"Tumour Biol"},{"issue":"7","key":"1673_CR30","doi-asserted-by":"crossref","first-page":"e69535","DOI":"10.1371\/journal.pone.0069535","volume":"8","author":"B Herrera","year":"2013","unstructured":"Herrera B, Garcia-Alvaro M, Cruz S, Walsh P, Fernandez M, Roncero C, et al. MP9 is a proliferative and survival factor for human hepatocellular carcinoma cells. PLoS One. 2013;8(7):e69535. doi: 10.1371\/journal.pone.0069535 .","journal-title":"PLoS One"},{"issue":"25","key":"1673_CR31","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1038\/sj.onc.1211020","volume":"27","author":"RA Eliseev","year":"2008","unstructured":"Eliseev RA, Dong YF, Sampson E, Zuscik MJ, Schwarz EM, O'Keefe RJ, et al. Runx2-mediated activation of the Bax gene increases osteosarcoma cell sensitivity to apoptosis. Oncogene. 2008;27(25):3605\u201314. doi: 10.1038\/sj.onc.1211020 .","journal-title":"Oncogene"},{"key":"1673_CR32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1746-6148-8-17","volume":"8","author":"RE Rici","year":"2012","unstructured":"Rici RE, Alcantara D, Fratini P, Wenceslau CV, Ambrosio CE, Miglino MA, et al. Mesenchymal stem cells with rhBMP-2 inhibits the growth of canine osteosarcoma cells. BMC Vet Res. 2012;8:17. doi: 10.1186\/1746-6148-8-17 .","journal-title":"BMC Vet Res"},{"issue":"3","key":"1673_CR33","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3892\/or.2013.2592","volume":"30","author":"JD Zhou","year":"2013","unstructured":"Zhou JD, Shen F, Ji JS, Zheng K, Huang M, Wu JC. FAM9C plays an anti-apoptotic role through activation of the PI3K\/Akt pathway in human hepatocellular carcinoma. Oncol Rep. 2013;30(3):1275\u201384. doi: 10.3892\/or.2013.2592 .","journal-title":"Oncol Rep"},{"issue":"5","key":"1673_CR34","doi-asserted-by":"crossref","first-page":"e62627","DOI":"10.1371\/journal.pone.0062627","volume":"8","author":"L Fan","year":"2013","unstructured":"Fan L, Song B, Sun G, Ma T, Zhong F, Wei W. Endoplasmic reticulum stress-induced resistance to doxorubicin is reversed by paeonol treatment in human hepatocellular carcinoma cells. PLoS One. 2013;8(5):e62627. doi: 10.1371\/journal.pone.0062627 .","journal-title":"PLoS One"},{"key":"1673_CR35","author":"Z Fu","year":"2013","unstructured":"Fu Z, Ren L, Wei H, Lv J, Che X, Zhu Z, et al. Effects of tyroserleutide on phosphatidylinositol 3'-kinase\/AKT pathway in human hepatocellular carcinoma cell. J Drug Target. 2013. doi: 10.3109\/1061186X.2013.844820 .","journal-title":"J Drug Target"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-1673-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-014-1673-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-1673-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T00:04:28Z","timestamp":1565222668000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-014-1673-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,27]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["1673"],"URL":"https:\/\/doi.org\/10.1007\/s13277-014-1673-y","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,27]]}}}